Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1752s-1756s, April 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.-J.
Right arrow Articles by Scully, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.-J.
Right arrow Articles by Scully, R.

BRCA1, BRCA2, and Rad51 Operate in a Common DNA Damage Response Pathway1

Jun-Jie Chen, Daniel Silver, Sharon Cantor, David M. Livingston2 and Ralph Scully

The Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115

2 To whom requests for reprints should be addressed, at The Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.

The two major hereditary breast cancer susceptibility genes, BRCA1 and BRCA2, are associated with early-onset breast and/or ovarian cancer and encode products that each interact with the product of the eukaryotic RecA homologue, hRad51. We have recently found that BRCA1 and BRCA2 coexist in a common biochemical complex. The two proteins also colocalize in subnuclear foci in somatic cells as well as on the axial elements of developing synaptonemal complexes in meiotic cells. Thus, BRCA1 and BRCA2 participate in a common DNA damage response pathway associated with the activation of homologous recombination and double-strand break repair. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and/or ovarian cancer. The BRCA1/BRCA2 complex may function in postreplicational repair processes activated during the DNA synthesis stage of the cell cycle.

1 Presented at the "General Motors Cancer Research Foundation Twentieth Annual Scientific Conference: Developmental Biology and Cancer," June 9–10, 1998, Bethesda, MD.

Received 2/ 5/99. Accepted 2/ 8/99.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
O. S. Gildemeister, J. M. Sage, and K. L. Knight
Cellular Redistribution of Rad51 in Response to DNA Damage: NOVEL ROLE FOR Rad51C
J. Biol. Chem., November 13, 2009; 284(46): 31945 - 31952.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
S.E. TSUTAKAWA and P.K. COOPER
Transcription-coupled Repair of Oxidative DNA Damage in Human Cells: Mechanisms and Consequences
Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 201 - 216.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
X. WU, G. RATHBUN, W.S. LANE, D.T. WEAVER, and D.M. LIVINGSTON
Interactions of the Nijmegen Breakage Syndrome Protein with ATM and BRCA1
Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 535 - 546.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.